Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease

J Neural Transm (Vienna). 2003 Sep;110(9):1041-50. doi: 10.1007/s00702-003-0018-6.

Abstract

The peroxisome proliferator-activated receptor alpha (PPAR-alpha) is a member of the steroid hormone super family of ligand-inducible transcription factors, involved in glucose and lipid metabolism. We screened for polymorphisms in the PPAR-alpha gene and detected two known polymorphisms located in exon 5 and intron 7. These polymorphisms were investigated for their possible association with Alzheimer's disease (AD) and for their effect in carriers of an insulin gene (INS) polymorphism. The PPAR-alpha C --> G polymorphism in exon 5 (L162V) was associated with AD, in that the V-allele was more frequent in AD patients than in healthy subjects. Further data analysis revealed that carriers of an PPAR-alpha L162V V-allele and an INS-1 allele presented with an increased risk for AD. Cerebrospinal fluid amyloid-beta levels were influenced by PPAR-alpha L162V genotype. These results suggest, that PPAR-alpha polymorphism may be a risk factor for AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism*
  • Amino Acid Substitution
  • Amyloid beta-Peptides / cerebrospinal fluid
  • DNA Mutational Analysis
  • Exons / genetics
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Insulin / genetics
  • Insulin / metabolism
  • Male
  • Middle Aged
  • Polymorphism, Genetic / genetics*
  • Receptors, Cytoplasmic and Nuclear / deficiency*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Transcription Factors / deficiency*
  • Transcription Factors / genetics

Substances

  • Amyloid beta-Peptides
  • Insulin
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors